This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
54,76 €
Share price
0.00%
Change (1 day)
6.21%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
EPS for Catalent (CTLT)
EPS in 2024 (TTM): -5,89 €
According to Catalent's latest financial reports the company's current EPS (TTM) is -5,46 €. In 2023 the company made an earnings per share (EPS) of -5,87 € a decrease over its 2022 EPS that were of 1,96 €.
EPS history for Catalent from 2014 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -5,89 € | 0.42% |
| 2023 | -5,87 € | -399.56% |
| 2022 | 1,96 € | -30.58% |
| 2021 | 2,82 € | 79.67% |
| 2020 | 1,57 € | 114.12% |
| 2019 | 0,73 € | -15% |
| 2018 | 0,86 € | 75.44% |
| 2017 | 0,49 € | -22.97% |
| 2016 | 0,64 € | -59.56% |
| 2015 | 1,58 € | 282.05% |
| 2014 | 0,41 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | 0,97 € | -117.85% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -0,65 € | -88.15% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | 6,75 € | -223.54% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | -1,28 € | -76.62% | 🇺🇸 USA |